SynthesisInternational journal of surgery (London, England)2026
Human papillomavirus (HPV) infection and prevalence of colorectal cancer: an updated systematic review and meta-analysis of global data.
Synthesis in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Posttransplant Malignant Neoplasms in Solid Organ Transplant Recipients.JAMA network open · 2026Article
- Why Is Colorectal Cancer Occurring Earlier? Metabolic Dysfunction, Underrecognized Carcinogens, and Emerging Controversies.Current obesity reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus (HPV), a known oncogenic virus in cervical and anal cancers, has also been detected in colorectal tissues. However, evidence regarding its association with colorectal cancer (CRC) remains inconsistent. We conducted an updated systematic review and meta-analysis to clarify this relationship.
methodsFollowing PRISMA 2020 guidelines, we systematically searched PubMed, Embase, Web of Science, and Cochrane Library through May 2025 for observational studies (case-control and cross-sectional) assessing HPV prevalence in CRC patients versus controls. Data extraction was performed in duplicate. Pooled odds ratios (ORs) were estimated using random-effects models with logit transformation. Subgroup analyses and meta-regression examined the effects of geographic region, HPV genotype, detection method, and sample type. Risk of bias was assessed using the Newcastle-Ottawa Scale.
findingsTwenty case-control studies encompassing 1424 CRC cases and 1363 controls were included. The pooled OR for the association between HPV infection and CRC was 2.39 (95% CI: 1.69-3.09), with no significant heterogeneity ( I2 = 0%). Associations were strongest in Asian studies (OR = 3.73) and in those using formalin-fixed paraffin-embedded (FFPE) tissues (OR = 3.56). Studies targeting HPV16 alone yielded higher effect sizes than those evaluating mixed or unspecified genotypes. Meta-regression confirmed region and genotype group as significant effect modifiers. Leave-one-out sensitivity analysis confirmed robustness. Egger's test indicated marginal small-study bias ( P = 0.074), but funnel plot symmetry suggested no serious publication bias.
conclusionThis meta-analysis confirms a significant link between HPV infection and colorectal cancer, suggesting HPV may play a broader oncogenic role beyond the anogenital tract. The findings highlight the need for genotype-aware, region-specific screening strategies, and support incorporating viral profiling into CRC prevention efforts, especially in underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.